DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Type I diabetes mellitus	R-HSA-5683209	map04940	lincomycin	3000540	drug-path
Olfactory transduction	R-HSA-9751605	map04740	griseofulvin	441140	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	griseofulvin	441140	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	griseofulvin	441140	drug-path
Cytokine-cytokine receptor interaction	R-HSA-6788467	map04060	griseofulvin	441140	drug-path
Olfactory transduction	R-HSA-9751605	map04740	dilazep	3074	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	dilazep	3074	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	dilazep	3074	drug-path
Apoptosis	R-HSA-109581	map04210	dilazep	3074	drug-path
Parkinson's disease	R-HSA-1643685	0	dilazep	3074	drug-path
Glioma	Q9NZM4	map05214	riluzole	5070	drug-path
T cell receptor signaling pathway	R-HSA-983705	map04660	riluzole	5070	drug-path
Olfactory transduction	R-HSA-9751605	map04740	riluzole	5070	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	riluzole	5070	drug-path
Primary immunodeficiency	R-HSA-5601905	map05340	riluzole	5070	drug-path
Acute myeloid leukemia	R-HSA-9680350	map05221	riluzole	5070	drug-path
ErbB signaling pathway	R-HSA-168638	map04012	riluzole	5070	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	riluzole	5070	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	riluzole	5070	drug-path
Apoptosis	R-HSA-109581	map04210	riluzole	5070	drug-path